Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Simin Qi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5085157734. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s12943-022-01538-4↗
  2. Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. First author DOI 10.1016/j.omtn.2021.06.015↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiang‐Jiang Qin · 2 shared papers, 2021–2022 · strength 0.26
  2. Xiaoqing Guan · 1 shared paper, 2022 · strength 0.15
  3. Weidong Zhang · 1 shared paper, 2022 · strength 0.15
  4. Wenjuan Yin · 1 shared paper, 2022 · strength 0.15
  5. Xiangdong Cheng · 1 shared paper, 2022 · strength 0.15
  6. Zhouyu Ning · 1 shared paper, 2021 · strength 0.11
  7. Libin Song · 1 shared paper, 2021 · strength 0.11
  8. Shengli Li · 1 shared paper, 2021 · strength 0.11
  9. Lanyun Feng · 1 shared paper, 2021 · strength 0.11
  10. Bo Zhang · 1 shared paper, 2021 · strength 0.11
  11. Luming Liu · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.